Xosomix LLC is a biotechnology company based in San Diego, CA, specializing in the development of next-generation therapeutics using exosomes. With a focus on brain disorders, Xosomix harnesses the targeting capability of exosomes to enhance the efficacy of current drugs and utilize the healing potential of exosomes to revolutionize the treatment of these conditions.
Founded on groundbreaking preclinical research, Xosomix is at the forefront of utilizing exosomes for therapeutic purposes, with their initial work demonstrating promising results in Rett Syndrome. As a resident of the prestigious biotech incubator JLABS by Johnson & Johnson Innovation, Xosomix is dedicated to advancing the field of exosome-based therapeutics and addressing the unmet needs in the $100 billion brain disorder therapeutics market.
Generated from the website